Login to Your Account

Pharma: Other news to note

Thursday, December 12, 2013
Iroko Pharmaceuticals LLC, of Philadelphia, said its affiliate, Iroko Pharmaceuticals Inc., has signed licensing agreements with Algorithm SAL and PT Pratapa Nirmala (Fahrenheit), under which the two companies will obtain the exclusive rights to market and sell pain drug Zorvolex (diclofenac) capsules to countries in the Middle East, North Africa and Indonesia, respectively.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription